References
Coweher K, Hanks GW (1990) Long term management of respiratory symptoms in advanced cancer. J Pain Sympt Manag 5:320–330
Bruera E, Ripamoni C (1998) Dyspnea in patients with advanced cancer. In: Berger A et al (ed) Principles and practices of supportive oncology, vol. 23. Lippincott–Raven, Philadelphia, pp 295–308
Filippelli M, Pacini F, Romagnoli I et al (2000) Airway obstruction and chronic exertional dyspnea in patients with persistent bronchial asthma. Respir Med 94(7):694–701
Frew AJ, Hogate ST (1993) Clinical pharmacology of asthma. Implications for treatment. Drugs 46:847–862
Weir Dc, Gove RI, Robertson AS et al (1991) Corticosteroids trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone diproprionate. Thorax 45:112–117
Schols Am, Soeters PB, Mostert R et al (1995) Physiologic effects of nutritional support and anabolic steroids in patients in patients with chronic obstructive pulmonary disease: a placebo controlled randomized trial. Am J Respir Crit Care Med 152:1268–1274
Geimer NF, Donegan WL (1980) Role and mechanism of corticosteroid therapy in breast cancer. Rev Endocr-Relat Cancer 6:5–6
Walsh TD, West TS (1988) Controlling symptoms in advanced cancer. Br Med J 296:477–481
Kveton JF, Pillsbury HC (1982) Conservative treatment of infantile subglottic hemangioma with corticosteroids. Arch Otolaryngol 108(2):117–119
Anonymous (1978) Treatment of complicated hemangiomas with adrenocorticosteroids when the integrity of important structures or life itself is threatened. J Dermatol Surg Oncol 4(11):854–858
Hawkins DB, Crockett DM, Kahlstrom EJ, MacLaughlin EF (1984) Corticosteroid management of airway hemangiomas: long-term follow-up. Laryngoscope 94(1):633–637
Mason BA, Dambra J, Grossman B et al (1982) Effective control of cisplatin-induced nausea using high-dose steroids and droperidol. Cancer 50:243–245
Schell H (1972) Adrenal corticosteroid therapy in far advanced cancer. Geriatric 27:131–141
Bruera E, Roca E, Cedaro L et al (1985) Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 69:751–754
Bruera E, MacEachern T, Ripamonti C et al (1993) Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med 119:906–907
Bruera E, Macmillan K, Pither J et al (1990) The effects of morphine on the dyspnea of terminal cancer patients. J Pain Sympt Manag 5:341–344
Cohen MH, Johnston Anderson A, Krasnow SH et al (1991) Continuous intravenous infusion of morphine for severe dyspnea. South Med J 84:229–234
Del Fabbro E, Dalal S, Bruera E (2006) Symptom control in palliative care–Part III: dyspnea and delirium. J Palliat Med 9(2):422–436 Review
Hilton G, Frei J (1991) High-dose methylprednisolone in the treatment of spinal cord injuries. Heart Lung 20(6):675–680
Muz J, Mathog RH, Nelson R, Jones LA Jr (2001) Aspiration in patients with head and neck cancer and tracheostomy. Am J Otolaryngol 10(4):282–286
Tanigawa N, Sawada S, Okuda Y et al (2000) Symptomatic improvement in dyspnea following tracheobronchial metallic stenting for malignant airway obstruction. Acta Radiol 41(5):694–701
Kim H (1998) Stenting therapy for stenosing airway disease. Respirology 4:221–228
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Elsayem, A., Bruera, E. High-dose corticosteroids for the management of dyspnea in patients with tumor obstruction of the upper airway. Support Care Cancer 15, 1437–1439 (2007). https://doi.org/10.1007/s00520-007-0305-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-007-0305-0